Clinical trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic…
NCT00381706 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00381706 |
|---|---|
| Title | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer |
| Official title | Randomized Phase II Study of ECF-C, IC-C, or FOLFOX-C in Metastatic Esophageal and GE Junction Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Bristol-Myers Squibb Industry Sanofi Pfizer |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Biological, Drug |
| Interventions | cetuximab, ECF, IC, FOLFOX |
| Enrollment | 245 |
| Start date | Sep 15, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Oct 15, 2014 |
| First posted | Sep 28, 2006 |
| Last update posted | Sep 29, 2021 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: